Literature DB >> 16941465

Case-control study of UCHL1 S18Y variant in Parkinson's disease.

Eng-King Tan1, Kim-Yoong Puong, Stephanie Fook-Chong, Eva Chua, Hui Shen, Yih Yuen, Ratnagopal Pavanni, Meng-Cheong Wong, Kathiravelu Puvan, Yi Zhao.   

Abstract

A recent meta-analysis observed a greater significant inverse association of the ubiquitin carboxy-terminal hydrolase L1 (UCHL1) S18Y variant with Parkinson's disease (PD) for Asian (predominantly Japanese) populations compared with Caucasian populations. We performed an independent case-control study in 335 PD and 341 control subjects with data from a Chinese population to investigate the age-of-onset effect of the UCHL1 variant in PD. The Y/Y and Y/S genotypes were less frequent in the PD young-onset group than in controls and the frequency of the Y alleles was higher in young controls compared to young-onset PD (age at examination <or= 65 years; P = 0.003). Multivariate analysis revealed the Y/Y genotype was significantly lower (P = 0.008) in the young-onset PD (Y/Y vs. S/S: odds ratio [OR]: 0.42; 95% confidence interval [CI]: 0.24, 0.74; S/Y vs. S/S: OR: 0.66, 95% CI: 0.41, 1.08) compared with controls, but this difference was not seen for the late-onset PD. Kaplan-Meier analysis carried out on PD subjects demonstrated that the Y/Y genotype was associated with a later onset of PD than Y/S plus S/S genotypes (P = 0.05). We provided an independent confirmation of the protective effect of the UCHL1 S18Y variant (Y/Y genotype) against PD in young Chinese subjects. Further functional studies of the S18Y variant in both cell and animal models will be of interest.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16941465     DOI: 10.1002/mds.21064

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  7 in total

Review 1.  Association between ubiquitin carboxy-terminal hydrolase-L1 S18Y variant and risk of Parkinson's disease: the impact of ethnicity and onset age.

Authors:  Ying Liu; Yan-Yan Chen; Hui Liu; Ci-Jiang Yao; Xiao-Xia Zhu; Dao-Jun Chen; Jin Yang; You-Jin Lu; Ji-Yu Cao
Journal:  Neurol Sci       Date:  2014-11-06       Impact factor: 3.307

Review 2.  Lack of association between UCHL1 S18Y gene polymorphism and Parkinson's disease in the Asian population: a meta-analysis.

Authors:  Shuang Sun; Yan Zhao; Guojiang Jin; Hui Kang
Journal:  Neurol Sci       Date:  2014-10-30       Impact factor: 3.307

3.  Lack of evidence for an association between UCHL1 S18Y and Parkinson's disease.

Authors:  Carolyn M Hutter; Ali Samii; Stewart A Factor; John G Nutt; Donald S Higgins; Thomas D Bird; Alida Griffith; John W Roberts; Berta C Leis; Jennifer S Montimurro; Denise M Kay; Karen L Edwards; Haydeh Payami; Cyrus P Zabetian
Journal:  Eur J Neurol       Date:  2007-12-18       Impact factor: 6.089

Review 4.  Parkinson's in the bone.

Authors:  Lei Xiong; Jin-Xiu Pan; Hao-Han Guo; Lin Mei; Wen-Cheng Xiong
Journal:  Cell Biosci       Date:  2021-11-05       Impact factor: 9.584

Review 5.  Association between the ubiquitin carboxyl-terminal esterase L1 gene (UCHL1) S18Y variant and Parkinson's Disease: a HuGE review and meta-analysis.

Authors:  Margaret Ragland; Carolyn Hutter; Cyrus Zabetian; Karen Edwards
Journal:  Am J Epidemiol       Date:  2009-10-28       Impact factor: 4.897

6.  Targeting the progression of Parkinson's disease.

Authors:  J L George; S Mok; D Moses; S Wilkins; A I Bush; R A Cherny; D I Finkelstein
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

7.  UCHL1 S18Y variant is a risk factor for Parkinson's disease in Japan.

Authors:  Yoshihiro Miyake; Keiko Tanaka; Wakaba Fukushima; Chikako Kiyohara; Satoshi Sasaki; Yoshio Tsuboi; Tatsuo Yamada; Tomoko Oeda; Hiroyuki Shimada; Nobutoshi Kawamura; Nobutaka Sakae; Hidenao Fukuyama; Yoshio Hirota; Masaki Nagai
Journal:  BMC Neurol       Date:  2012-07-28       Impact factor: 2.474

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.